SINOVAC BIOTECH LTD

SVA ·Healthcare, Drug Manufacturers - General
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $20.0M
Depreciation & Amortization $2.2M
Depreciation —
Amortization —
Stock-Based Compensation $422.9K
Net Cash from Operating Activities $48.4M
Investing Activities
Capital Expenditures $4.3M
Business Acquisitions —
Net Cash from Investing Activities —
Financing Activities
Dividends Paid $3.8M
Stock Repurchases $335.8K
Net Cash from Financing Activities —
Net Change in Cash —
Free Cash Flow $44.1M
← Newer Page 3 of 3 Older →